Dare slot comparison — The Five Fund Frame

Park Earn Build Roam Dare
Dare Funds Compared: ARKK vs IBIT vs SMH vs XBI

Which thematic/concept ETF belongs in your Dare slot?

Dare Fund Comparison — ARKK vs IBIT vs SMH vs XBI

This is analysis, not personalized investment advice. Do your own homework before making decisions.

Quick Verdict

The Dare slot is where you put money you're willing to lose — these are high-risk, high-potential thematic bets that have nothing to do with diversification. ARKK is an actively managed disruption fund. IBIT gives you direct Bitcoin exposure. SMH concentrates on semiconductors. XBI bets on biotech innovation. None of them belong in a conservative portfolio, and all of them belong in the Dare slot specifically because they're volatile enough to test your conviction.

Side-by-side comparison

FeatureARKK (Cathie Wood)IBIT (BlackRock)SMH (VanEck)XBI (SPDR)
Ticker ARKK IBIT SMH XBI
SponsorARK InvestBlackRock (iShares)VanEckState Street (SPDR)
Expense Ratio0.75%0.25%0.35%0.35%
AUM~$7B~$40B+~$35B~$7B
StrategyActive disruption themeBitcoin spot priceSemiconductor companiesBiotech innovation
Holdings~35-45 (active)N/A (single asset)~30~80
YieldN/AN/A~0.5%N/A
Volatility (5-yr)Very highVery highHighHigh
Max drawdown (5-yr)~80%+~55%+~60%~70%
Best year (5-yr)+150% (2020)+130% (2024)+65% (2023)+55% (2024)
Worst year (5-yr)-67% (2022)-25% (2022)-35% (2022)-40% (2021)

Verify current data with fund sponsors. Numbers change daily.

The key takeaway

All four funds are high-risk thematic bets with extreme volatility and significant drawdown potential. ARKK is the most volatile (80%+ max drawdown) but also had the biggest single-year gain (+150%). IBIT is the newest and has grown to massive AUM quickly, reflecting strong Bitcoin demand. SMH benefits from the AI/semiconductor boom but is concentrated in a single sector. XBI is the most diversified Dare pick with ~80 holdings but still carries significant biotech-specific risk.

The expense ratios vary dramatically — ARKK at 0.75% is 15x more expensive than VOO, while IBIT at 0.25% is the cheapest Dare option. For a slot that's supposed to be small (5-10% of portfolio), the cost difference matters less than it does for Build, but it's still worth noting.

ARKK — Active thematic disruption

ARK Innovation ETF (ARKK) is the most controversial and polarizing fund in the market. Managed by Cathie Wood, it concentrates on companies involved in "disruptive innovation" — genomics, fintech, automation, AI, and blockchain. The fund is actively managed with a 0.75% expense ratio, which is extremely high for an ETF.

ARKK's performance has been extreme: +150% in 2020, -67% in 2022. It's the kind of fund that makes investors either love it or hate it, with little middle ground. The active management means performance depends entirely on Cathie Wood's stock-picking ability, which has been mixed at best over the fund's 7-year history.

ARKK is the purest Dare pick — high risk, high potential, and entirely dependent on a single manager's vision. Only for investors who can stomach 80% drawdowns and still hold.

IBIT — Bitcoin spot ETF

iShares Bitcoin Trust (IBIT) gives you direct exposure to Bitcoin's price movement through a regulated ETF structure. Launched in January 2024, it has grown to over $40 billion in assets in under two years — the fastest-growing ETF in history. It holds actual Bitcoin (not futures contracts), charges 0.25%, and tracks the spot price of Bitcoin.

Bitcoin is the most volatile major asset class in existence. It has experienced multiple 50%+ drawdowns and multiple 300%+ rallies. IBIT makes it easy to add Bitcoin exposure to a Dare slot without dealing with crypto exchanges, wallets, or custody. The 0.25% expense ratio is reasonable for Bitcoin exposure — comparable to what you'd pay on a crypto exchange.

IBIT is the simplest way to add Bitcoin to your portfolio. It's volatile, unpredictable, and belongs in the Dare slot — but it's also the most straightforward thematic bet on this list.

SMH — Semiconductor concentration

Semiconductor ETF (SMH) concentrates on the semiconductor industry — the companies that make the chips powering AI, data centers, smartphones, and everything else. It holds ~30 stocks with heavy concentration in NVIDIA (~22%), TSMC (~15%), and Broadcom (~10%). The fund has benefited enormously from the AI boom, delivering +65% in 2023.

The concentration risk is significant — NVIDIA alone represents nearly a quarter of the fund. If NVIDIA stumbles, SMH stumbles hard. But if semiconductors continue their secular growth trajectory (driven by AI, edge computing, and automotive electrification), SMH is one of the cleanest ways to play that thesis.

SMH is a focused bet on semiconductors — the backbone of modern technology. High concentration in NVIDIA is both the fund's strength and its biggest risk.

XBI — Biotech speculation

S&P Biotechnology ETF (XBI) holds ~80 biotech companies, with a tilt toward small and mid-cap stocks. Unlike many biotech ETFs that concentrate on large pharma, XBI focuses on innovative smaller companies developing new drugs and therapies. This makes it more volatile but also gives it higher upside potential if the biotech sector rallies.

Biotech is a binary outcome industry — drugs either work or they don't, and regulatory decisions can make or break companies overnight. XBI's ~80 holdings provide some diversification, but the entire sector is subject to FDA approval risk, patent cliffs, and clinical trial failures. It's a speculative bet on medical innovation.

XBI is the most diversified Dare pick but also one of the most speculative. Biotech's binary outcomes mean XBI can swing 40%+ in either direction based on sector sentiment alone.

Who should use what

Investor profileRecommended fundWhy
Believe in Bitcoin long-termIBITSimplest Bitcoin exposure, largest AUM
Bet on AI/semiconductor boomSMHPure semiconductor play, AI tailwinds
Bet on biotech innovationXBIMost diversified biotech exposure
Bet on Cathie Wood's visionARKKActive disruption theme, highest risk/reward
Want multiple Dare betsIBIT + SMHDiversify across uncorrelated themes

The honest answer: IBIT and SMH are the most compelling Dare picks for most investors. Bitcoin has established itself as a legitimate asset class, and semiconductors have secular growth tailwinds from AI. ARKK is too dependent on a single manager, and XBI's biotech risk is harder to evaluate. But all four belong in the Dare slot specifically because they're volatile enough to test your conviction — and that's exactly what the Dare slot is for.

Data sources: Expense ratios from issuer websites and SEC filings (EDGAR). Yield data from fund fact sheets. Last verified: June 02, 2026. Fund metrics change over time — always verify current figures at the sources above before making investment decisions.